Jump to content

OmniVis: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Declining submission: corp - Submission is about a company or organization not yet shown to meet notability guidelines (AFCH 0.9.1)
GreenC bot (talk | contribs)
Bots
2,552,698 edits
 
(28 intermediate revisions by 9 users not shown)
Line 1: Line 1:
{{Short description|US biotech company}}
{{AFC submission|d|corp|u=CT55555|ns=118|decliner=S0091|declinets=20211106001305|ts=20211103002115}} <!-- Do not remove this line! -->
{{Orphan|date=February 2022}}
{{AFC submission|d|npov|u=CT55555|ns=118|decliner=Nomadicghumakkad|declinets=20211101204439|small=yes|ts=20211101185316}} <!-- Do not remove this line! -->


{{Infobox company
{{AFC comment|1=Remove all non-notable awards to start with. [[User:Nomadicghumakkad|Nomadicghumakkad]] ([[User talk:Nomadicghumakkad|talk]]) 20:44, 1 November 2021 (UTC)}}

----

⚫
'''OmniVis''' is a US-based company that specialises in rapid medical diagnostic tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref>

{{Company
| name = OmniVis
| name = OmniVis
| logo = OmniVis logo.png
| industry = [[Biotechnology]]
| founded = 2017
| founded = 2017
| hq_location = San Francisco, California, USA
| hq_location = [[San Francisco]]
| key_people = Katherine Clayton, CEO
| key_people = Katherine Clayton, CEO
| website = www.omnivistech.com
| website = www.omnivistech.com
}}
}}
[[File:TechCrunch Disrupt San Francisco 2019 - Day 1 (48834421858).jpg|thumb|Dr Katherine Clayton of OmniVis at [[TechCrunch]] Disrupt San Francisco 2019]]
⚫
'''OmniVis''' is a [[South San Francisco]] based biotechnology company that specializes in rapid [[Medical diagnosis|medical diagnostic]] tests.<ref name=":0">{{Cite news|last=Joe Palca and Susie Neilson|date=7 Aug 2019|title=This Handy New Device Might Help KO Cholera|language=en|work=NPR.org|url=https://www.npr.org/sections/goatsandsoda/2019/08/07/749100484/this-handy-new-device-might-help-kayo-cholera|access-date=2021-10-31}}</ref><ref>{{Cite web|date=2019-02-15|title=Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test|url=https://www.genomeweb.com/pcr/purdue-spinout-omnivis-commercializing-smartphone-based-cholera-test|access-date=2021-11-02|website=Genomeweb|language=en}}</ref><ref>Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii</ref> Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.


== Diagnostic tests ==
== Products ==


=== Cholera ===
=== Cholera detection ===
OmniTech rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in approximately 30 minutes.<ref name=":0" /> OmniTech uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://social.techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|url-status=live|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref>, it costs approximately US$10 per test.<ref name=":2" /> The processing is done on an [[Android (operating system)|Android]] [[smartphone]]<ref name=":2" /> that analyses water samples that are put into a single use test kit element.<ref name=":0" />
OmnniVis's rapid [[Cholera]] detection device can identify the presence of ''[[Vibrio cholerae]]'' in water in less than one hour.<ref>{{Cite web |last=Service |first=Purdue News |title=‘Cholera detection lab’ smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research |url=https://www.purdue.edu/newsroom/releases/2019/Q3/cholera-detection-lab-smartphone-enabled-platform-to-be-beta-tested-by-worldwide-leading-hospital-in-cholera-research.html |access-date=2023-11-20 |website=www.purdue.edu |language=en}}</ref> The device uses a process of [[Gene amplification|DNA amplification]] and [[viscosity]] measurement.<ref name=":2">{{Cite web|last=Coldewey|first=Devin|date=2 Oct 2019|title=OmniVis could save lives by detecting cholera-infected water in minutes rather than days|url=https://techcrunch.com/2019/10/02/omnivis-could-save-lives-by-detecting-cholera-infected-water-in-minutes-rather-than-days/|access-date=2021-10-31|website=TechCrunch|language=en-US}}</ref>


The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.<ref name=":0" /> In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.<ref name=":0" />
The current design is not well suited for large scale testing due to the small volume that can be tested.<ref name=":0" />


=== COVID-19 ===
=== COVID-19 detection ===
In May 2020 OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva<ref name=":4">{{Cite web|date=2021-10-12|title=People Behind CSR at Cisco: Early-stage tech entrepreneurs get a boost from Cisco’s Global Problem Solver Challenge|url=https://blogs.cisco.com/csr/people-behind-csr-at-cisco-early-stage-tech-entrepreneurs-get-a-boost-from-ciscos-global-problem-solver-challenge|access-date=2021-10-31|website=Cisco Blogs|language=en-US}}</ref>. The rapid tests uses a smartphone for processing.<ref name=":3" />
In May 2020, OmniVis was working on the early stages of a [[Rapid diagnostic test|rapid test]] for [[COVID-19]]<ref name=":3">{{Cite news|last=Marcus|first=Brianna Abbott and Amy Dockser|date=2020-05-26|title=Race Is On to Create Rapid Covid-19 Tests for the Fall|language=en-US|work=Wall Street Journal|url=https://www.wsj.com/articles/race-is-on-to-create-rapid-covid-19-tests-for-the-fall-11590494400|access-date=2021-10-31|issn=0099-9660}}</ref> that detects the disease in human saliva. The rapid tests uses a smartphone for processing.<ref name=":3" /> The project was supported by the [[United States Department of Agriculture]].<ref>{{Cite web|title=COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC|url=https://portal.nifa.usda.gov/web/crisprojectpages/1024206-covid-19-rapid-response-a-handheld-diagnostic-device-for-covid-19-in-meat-and-poultry-processing-facilities.html|access-date=2021-12-17|website=portal.nifa.usda.gov}}</ref> From June 2020, OmniVis was also working on a United States [[National Science Foundation]] funded initiative to detect COVID-19 from nasal swabs.<ref>{{Cite web|title=NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform|url=https://www.nsf.gov/awardsearch/showAward?AWD_ID=2028308&HistoricalAwards=false|access-date=2021-12-17|website=www.nsf.gov}}</ref>

== Key people ==
Katherine Clayton PhD, Founder & CEO.<ref name=":0" />


== References ==
== References ==

<!-- Inline citations added to your article will automatically display here. See en.wikipedia.org/wiki/WP:REFB for instructions on how to add citations. -->
{{reflist}}
{{reflist}}

== External links ==

* [https://www.omnivistech.com/ Official website]

[[Category:Biotechnology companies of the United States]]
[[Category:Biotechnology companies established in 2017]]

Latest revision as of 04:59, 26 July 2024

OmniVis
IndustryBiotechnology
Founded2017
HeadquartersSan Francisco
Key people
Katherine Clayton, CEO
Websitewww.omnivistech.com
Dr Katherine Clayton of OmniVis at TechCrunch Disrupt San Francisco 2019

OmniVis is a South San Francisco based biotechnology company that specializes in rapid medical diagnostic tests.[1][2][3] Co-founded by Dr. Katherine Clayton, a Purdue College of Engineering graduate alumna, and three professors, OmniVis produces cholera test and is working on COVID-19 tests.

Products

[edit]

Cholera detection

[edit]

OmnniVis's rapid Cholera detection device can identify the presence of Vibrio cholerae in water in less than one hour.[4] The device uses a process of DNA amplification and viscosity measurement.[5]

The processing is done via a smartphone enabled platform that analyzes water samples inserted into a single-use test kit element.[1] In May 2019, OmniVis teamed up with the International Cetre for Diarrhoeal Disease Research, Bangladesh to beta test the technology.[1]

COVID-19 detection

[edit]

In May 2020, OmniVis was working on the early stages of a rapid test for COVID-19[6] that detects the disease in human saliva. The rapid tests uses a smartphone for processing.[6] The project was supported by the United States Department of Agriculture.[7] From June 2020, OmniVis was also working on a United States National Science Foundation funded initiative to detect COVID-19 from nasal swabs.[8]

References

[edit]
  1. ^ a b c Joe Palca and Susie Neilson (7 Aug 2019). "This Handy New Device Might Help KO Cholera". NPR.org. Retrieved 2021-10-31.
  2. ^ "Purdue Spinout OmniVis Commercializing Smartphone-Based Cholera Test". Genomeweb. 2019-02-15. Retrieved 2021-11-02.
  3. ^ Prashantham, Shameen. Gorillas Can Dance: Lessons from Microsoft and Other Corporations on Partnering with Startups. United Kingdom: Wiley, 2021. p.p. lviii
  4. ^ Service, Purdue News. "'Cholera detection lab' smartphone-enabled platform to be beta tested by worldwide leading hospital in cholera research". www.purdue.edu. Retrieved 2023-11-20.
  5. ^ Coldewey, Devin (2 Oct 2019). "OmniVis could save lives by detecting cholera-infected water in minutes rather than days". TechCrunch. Retrieved 2021-10-31.
  6. ^ a b Marcus, Brianna Abbott and Amy Dockser (2020-05-26). "Race Is On to Create Rapid Covid-19 Tests for the Fall". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-10-31.
  7. ^ "COVID-19 Rapid Response: A Handheld Diagnostic Device for COVID-19 in Meat and Poultry Processing Facilities - OMNIVIS INC". portal.nifa.usda.gov. Retrieved 2021-12-17.
  8. ^ "NSF Award Search: Award # 2028308 - SBIR Phase I: COVID-19 Detection on a Handheld Smartphone-Enabled Platform". www.nsf.gov. Retrieved 2021-12-17.
[edit]
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=OmniVis&oldid=1236711349"